Publications

Publications

Scientific publications

Editorials and Commentaries

Scientific Presentations

The Lancet (June 2020): Kuderer et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Cancer Discovery (October 2020): Rivera et al. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study
Annals of Oncology (March 2021) Grivas et al. Association of Clinical Factors and Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium
JAMA Oncology (June, 2021) Thompson et al. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Journal of Thrombosis and Haemostasis (July, 2021) Li et al. The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19.
JAMA Network Open (November, 2021) Schmidt, Tucker et al. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.

Scientific Presentations

Editorials and Commentaries

Scientific Presentations

ASCO 2020 LBA110 (Warner; May 28, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)
ISTH 2020 Congress (Rosovsky; July 12-14, 2020) Venous Thrombotic Complications in Cancer Patients with SARS-CoV-2 Infection: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Analysis
AACR COVID-19 and Cancer virtual meeting (Peters; July 21, 2020): Flexibility to sustain solidity: Addressing new vulnerabilities in cancer at the time of COVID-19
AACR COVID-19 and Cancer virtual meeting (Rini; July 22, 2020): Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC-19) and other COVID consortiums
ESMO 2020 LBA71 (Wise-Draper; Sep 19, 2020): Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
ESMO 2020 LBA72 (Grivas; Sep 20, 2020): Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
Blood (2020) 136 (Supplement 1): 28–30: Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
ASH 2020 #204 (Li; Dec 5, 2020) Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
SABC 2021 # PS7-01 (Khaki; Dec, 2020) Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study
ACC 2021 (Moey; May 16, 2021) Clinical characteristics and outcomes in cardio-oncology patients with covid-19: analysis from the covid-19 and cancer consortium (CCC19) database
ASCO 2021 # 4529 (Schmidt; June, 2021) Effect of Bacillus Calmette-Guerin (BCG) exposure on severity of COVID-19 infection: A COVID-19 and Cancer Consortium (CCC19) study.
ASCO 2021 # 6500 (Nagaraj; June, 2021) Racial and ethnic disparities among patients with breast cancer and COVID-19.
ASCO 2021 # 6561 (Enriquez; June, 2021) Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study
ASCO 2021 # 6563 (Shah; June, 2021) Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.
ASCO 2021 # 12035 (Loggers; June, 2021) Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis.
ASCO 2021 # e18788 (Gulati; June, 2021) Thrombotic complications with SARS-CoV-2 infection in patients with cancer on high-risk therapies: Data from the COVID-19 and Cancer Consortium (CCC19).

Editorials and Commentaries

Editorials and Commentaries

Editorials and Commentaries

The Cancer Letter (Mar 20, 2020): COVID-19 and Cancer Consortium
AACR Blog (Mar 25, 2020): COVID-19 and Cancer Consortium Forms to Collect and Share Information
Nature Cancer (Apr 21, 2020): Crowdsourcing a crisis response for COVID19 in Oncology
Cancer Cell (Apr 27, 2020): The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer
The Cancer Letter (May 22, 2020): CCC19 bridging the knowledge gap for patients with COVID-19 and cancer
The Cancer Letter (May 29, 2020): CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19
The Lancet (May 29, 2020): Cancer and COVID-19: what do we really know?
JCO Clinical Cancer Informatics (June 17, 2020): Crowdsourcing in Crisis: Rising to the Occasion
Cancer Cell (Dec 14, 2020): The COVID-19 and Cancer Consortium - A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19:CCC19 Governance, Protocol, and Quality Assurance
Advances in Radiation Oncology (October 29, 2020): The COVID-19 and Cancer Consortium (CCC19) and Opportunities for Radiation Oncology
The Cancer Letter (March 19, 2021) The COVID-19 and Cancer Consortium - A year into building a United Front against the SARS-CoV-2 pandemic
Cancer Cell (15 April 2021): Care without a compass: including patients with cancer in COVID-19 studies
Journal of the National Cancer Institute (28 August 2021): COVID-19 Vaccine among Actively-Treated People with Cancer: A Glimpse into the Known Unknowns?

Media

Podcasts/Interviews

Editorials and Commentaries

OncLive (Mar 18, 2020): Cancer Registry Launches to Inform COVID19+ Patient Demographics
Cancer Network (Mar 20, 2020): CCC19 Registry Launched to Understand COVID-19 in Patients with Cancer
ASCO Daily News (Mar 25, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data
Urotoday (Mar 25, 2020): COVID19 and Cancer Consortium (CCC19)
ASCO Daily News (Mar 26, 2020): Cancer Consortium Launches COVID19 Registry in Urgent Appeal for Data to Save Lives at Risk from Infection
ASCO Post (Mar 27, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data
Medicine Matters Oncology (Mar 27, 2020): COVID-19 cancer registry launched in the USA
Onconews, Brazil (Mar 28, 2020): Intitative gathers data on COVID-19 and cancer
Practice Update (Apr 1, 2020): Immediate Impact of COVID-19 on Cancer Care at Major Institutions.
SWOG: The Front Line (Apr 3, 2020): COVID Registry gets its start on Twitter
ASH Clinical News (Apr 9, 2020): COVID19, Cancer and Need for Clarity
British Medical Journal News (Apr 17,2020): COVID19 is shattering US cancer care
OncLive (Apr 18,2020): COVID19 and Cancer Consortium Gains International Ground
Frontline (May 4,2020): As Pandemic claims non-COVID patients, some face difficult decisions
Cancer Therapy Advisor (May 7, 2020) : Researchers Turn to Crowdsourcing To Learn More About COVID19 and Cancer
Associated Press (May 28, 2020): Cancer, coronavirus are a dangerous mix, new studies find
Cancer Network (May 28,2020): Cancer Progression Linked to Increased Risk of Death within 30 days of COVID19 diagnosis
CNN (May 28, 2020): How having cancer can put Covid-19 patients at higher risk of dying
MedPageToday (May 28, 2020): HCQ Linked to Harm in Cancer Patients
Reuters Health News (May 28, 2020): Hydroxychloroquine combination risky for cancer patients with COVID19
USA Today (May 28,2020): New study shows more cancer patients die from COVID19, but not necessarily for the reasons you'd expect
Wall Street Journal (May 28, 2020): Higher Death Rates Found Among Cancer Patients with COVID19
Medscape (May 29, 2020): Active Cancer Increases Death Risk in Patients With COVID-19
The Financial Express (May 30, 2020): Death Risk higher in cancer patients
healthline (June 9, 2020): People with Cancer Have to Choose Between Treatment and COVID-19 Risks
ASCO Post (June 12, 2020): Factors Associated With All-Cause 30-Day Mortality in Patients With Cancer Infected With COVID-19: CCC19 Database Analysis
Medscape (June 17, 2020): From a Tweet to the Lancet in 10 Weeks: COVID-Cancer Consortium
ASCO Post (June 24, 2020): Results of a COVID19 and Cancer Consortium (CCC19) Cohort Study
ASCO Post (June 25, 2020): COVID19 and Patients with Cancer: A Call to Action for Trainees
Medscape (July 27, 2020): CCC19, Other Registries Help Define COVID-19/Cancer Landscape
Elemental by Medium (August 5, 2020): The Unique Devastation of Cancer in a Pandemic
Healio (August 5, 2020): Hydroxychloroquine regimens for COVID-19 linked to mortality risk for patients with cancer
Cancer Therapy Advisor (August 12, 2020): The Twitter Effect on How Oncologists Conduct and Share Research
VUMC Reporter (Feb. 5, 2021): Convalescent plasma improved survival in COVID-19 patients with blood cancers
UroToday (March 22, 2021): COVID-19 and Cancer Consortium Study Highlights Increased Mortality and Racial Disparities for Patients with Cancer Diagnosed with SARS-CoV-2 Infection
Onconews, Brazil (March 23, 2021): CCC19: Clinical factors, cancer treatment and severity of COVID-19 in cancer patients
Onconews, Brazil (March 23, 2021): CCC19: Clinical factors, cancer treatment and severity of COVID-19 in cancer patients
UT Health News (June 17, 2021) Blood cancer patients with COVID-19 fare better with convalescent plasma
Washington University School of Medicine News (June 17, 2021) Blood cancer patients with COVID-19 fare better with convalescent plasma
The Milwaukee Journal Sentinel (July 7, 2021) Plasma from recovered COVID patients shows remarkable effectiveness for patients with coronavirus, blood cancer
Cancer Therapy Advisor (November 15, 2021) High Rate of Complications Reported in Sarcoma Patients With COVID-19

Podcasts/Interviews

Podcasts/Interviews

Podcasts/Interviews

ASCO Daily News (Mar 27, 2020): COVID19: How to Care for Patients With Cancer In a Global Pandemic
OncLive (Mar 30, 2020): Collaborative efforts lead to launch of COVID19 and Cancer Consortium registry
The Video Journal of Oncology (May 30, 2020): CCC19: COVID-19 and cancer
Practice Update (Mar 30, 2020): COVID19 registry for cancer patients: Rationale
IDSA COVID 19 Podcast (Apr 1, 2020): COVID19: What's Happening Now?
VuMedi (Apr 1, 2020): COVID-19 Pandemic: Preparation Protocols, Telemedicine and Modifying Treatment for Cancer Patients
eCancer (Apr 9, 2020): How COVID19 is impacting cancer patient care and clinical research
VuMedi (Apr 17, 2020): What is the COVID19 Cancer Consortium? Urgent need to generate knowledge on COVID19
OncLive (Apr 20, 2020): Dr. Choueiri on COVID19 and Cancer Consortium
Onconews (Apr 26, 2020): Crowdsourcing, COVID-19 and oncology
eCancer (May 13, 2020): The COVID19 and Cancer Consortium
Onconews (May 29, 2020): Global consortium shows results on cancer and COVID-19
Uromigos (May 29, 2020): Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC-19)
CancerNetwork (May 29, 2020): Petros Grivas, MD, PhD, on the Future of the CCC19 Registry
VJOncology (May 30, 2020): CCC19: COVID-19 and cancer
ecancer (31 May, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)
Medicine Matters oncology (1 June, 2020): Initial data from CCC19
CancerNetwork (July 28, 2020): Jeremy L. Warner, MD, MS, on Updated Findings from the COVID-19 and Cancer Consortium
OnLive (August 14, 2020): Dr. Choueiri on the Significance of the CCC19 During the COVID-19 Crisis
Oncology Learning Network (Aug 18, 2020): Dr Lyman and Dr Desai Talk COVID-19, Cancer Care, and the CCC19 Initiative
OBRoncology (Sep 24, 2020): Petros Grivas, MD, PhD, discusses the COVID-19 and Cancer Consortium (CCC19) from ESMO 2020
VJOncology (Oct 2, 2020): CCC19: assessment of clinical and laboratory prognostic factors
VJOncology (Oct 5, 2020): CCC19: systemic cancer treatment-related outcomes
VuMedi (May 20, 2021): COVID-19 Severity Among Patients with Cancer (2021 Analysis): Which Anti-Cancer Drugs and Regimens Have High Associated Mortality?